EMA updates Timelines of eAFs for Variations for Medicinal Products for Human Use
Recommendation
20 October 2026
Copenhagen, Denmark
An ECA Course prior to the 29th APIC/CEFIC Global GMP & Regulatory API Conference
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In future, submissions of variation notifications for medicinal products for human use are to be made exclusively via the electronic application forms (eAFs). The timelines for the full implementation of these systems have now been updated again and are listed on the EMA website in the PLM Portal (Product Lifecycle Management Portal).
Under the heading "What's New in PLM?" the newly defined timelines are shown and illustrated in the two-page document made available there. The mandatory use of electronic application forms is set for the end of the third quarter or the beginning of the fourth quarter of 2024 after a six-month transition period.
Please see the EMA website for the updated timelines and further information on the implementation of the electronic submission of variation notifications.
Related GMP News
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
14.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
07.10.2026EDQM Updates Guidance on CEP Sister File Applications
23.09.2026IRIS Portal: EMA expands digital Procedure Management
16.09.2026EMA updates Procedural Guidance for Application Preparation